Rchr
J-GLOBAL ID:201801021155538550   Update date: May. 21, 2024

Kawamura I. Yuki

Kawamura I. Yuki
Affiliation and department:
Research field  (1): Gastroenterology
Research keywords  (5): 糖鎖 ,  免疫 ,  癌 ,  炎症 ,  消化器
Research theme for competitive and other funds  (17):
  • 2022 - 2025 気管支上皮および肺胞上皮幹細胞特異的に発現する新規分子の機能解析
  • 2022 - 2025 乳幼児RSウイルス感染予防に向けた腸管を主眼とする新たな試み
  • 2020 - 2023 Starvation response of the immune system along the gut-bone marrow axis
  • 2020 - 2023 水分保持力を軸にしたムチン機能における腸内細菌叢由来代謝物の関連性
  • 2019 - 2022 Molecular functions of a novel gene exclusively expressed in esophageal basal cells
Show all
Papers (67):
  • Kazunori Matsumura, Taizo Mori, Taeko Dohi, Yuki I Kawamura, Satoshi Takaki. Composition of fatty acids in a high-fat diet affects adipose tissue inflammation by inducing calreticulin on adipocytes and activating group 1 innate lymphoid cells. European journal of immunology. 2024. e2350800
  • Hiroaki Shiratori, Kisara M Hattori, Kazuaki Nakata, Takuma Okawa, Seiga Komiyama, Yusuke Kinashi, Yuma Kabumoto, Yuria Kaneko, Motoyoshi Nagai, Tomoko Shindo, et al. Purified diet affects intestinal epithelial proliferation and barrier functions through gut microbial alterations. International immunology. 2024
  • Akira Shimomura, Teruki Hagiwara, Kazuhiko Yamada, Chizu Yokoi, Masayoshi Terayama, Kyoko Nohara, Toru Igari, Yuki I. Kawamura. Induction of Kallikrein-Related Peptidase 13 and TET2/3 by Anticancer Drugs and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma After Preoperative Treatment. Annals of Surgical Oncology. 2024. 31. 1. 251-261
  • Akira Shimomura, Kazuhiko Yamada, Yuki I. Kawamura. ASO Author Reflections: Prognostic Significance of Kallikrein-Related Peptidase 13 Induction After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 2024. 31. 1. 243-244
  • Ryusuke Sumiya, Kazuhiko Yamada, Teruki Hagiwara, Satoshi Nagasaka, Hideki Miyazaki, Toru Igari, Yuki I Kawamura. Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma. Molecular and clinical oncology. 2023. 19. 2. 64-64
more...
MISC (162):
more...
Patents (2):
Association Membership(s) (6):
THE JAPANESE SOCIETY FOR MUCOSAL IMMUNOLOGY ,  THE JAPANESE SOCIETY OF CARBOHYDRATE RESEARCH ,  THE JAPANESE SOCIETY FOR IMMUNOLOGY ,  THE JAPANESE BIOCHEMICAL SOCIETY ,  JAPANESE SOCIETY OF GASTROENTEROLOGY ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page